• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

cancer drugs

3D rendering of chromosomes and circular extrachromosomal DNA
Research

Drug shrinks tumors in mice by targeting extrachromosomal DNA

The compound from Boundless Bio shrank gastric tumors and prevented the cancer from developing resistance to another cancer drug.
Darren Incorvaia Nov 6, 2024 12:50pm
kidney cancer renal cell carcinoma tumor

Arcus drops promising data on HIF-2a candidate in kidney cancer

Oct 24, 2024 2:48pm
Cell division process

Volastra taps CSO as it looks to expand research horizons

Oct 16, 2024 7:00am
A 3D rendering of the COVID-19 virus SARS-CoV-2 Most of the virus particles are blue with a bright red one in the center

Infinity Pharma cancer drug stops COVID, MRSA damage in mice

Jul 9, 2024 7:00am
Pythagorean theorem

ASCO: It's back to the basics for cancer drug developers

Jun 5, 2024 10:55am
IPO initial public offering markets raise financing

Clinical-stage cancer biotech Actuate latest to eye summer IPO

May 28, 2024 9:45am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings